These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 23465346)

  • 1. Stem cell therapy is a promising tool for refractory angina: a meta-analysis of randomized controlled trials.
    Li N; Yang YJ; Zhang Q; Jin C; Wang H; Qian HY
    Can J Cardiol; 2013 Aug; 29(8):908-14. PubMed ID: 23465346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Cell Therapy on Myocardial Perfusion and Cardiovascular Outcomes in Patients With Angina Refractory to Medical Therapy: A Systematic Review and Meta-Analysis.
    Khan AR; Farid TA; Pathan A; Tripathi A; Ghafghazi S; Wysoczynski M; Bolli R
    Circ Res; 2016 Mar; 118(6):984-93. PubMed ID: 26838794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intramyocardial autologous CD34+ cell therapy for refractory angina: A meta-analysis of randomized controlled trials.
    Velagapudi P; Turagam M; Kolte D; Khera S; Hyder O; Gordon P; Aronow HD; Leopold J; Abbott JD
    Cardiovasc Revasc Med; 2019 Mar; 20(3):215-219. PubMed ID: 29908826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive meta-analysis of stem cell therapy for chronic angina.
    Shah R; Latham SB; Khan SA; Shahreyar M; Hwang I; Jovin IS
    Clin Cardiol; 2018 Apr; 41(4):525-531. PubMed ID: 29664162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34(+) Cell Administration in Patients With Refractory Angina.
    Povsic TJ; Henry TD; Traverse JH; Fortuin FD; Schaer GL; Kereiakes DJ; Schatz RA; Zeiher AM; White CJ; Stewart DJ; Jolicoeur EM; Bass T; Henderson DA; Dignacco P; Gu Z; Al-Khalidi HR; Junge C; Nada A; Hunt AS; Losordo DW;
    JACC Cardiovasc Interv; 2016 Aug; 9(15):1576-85. PubMed ID: 27491607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials.
    Stergiopoulos K; Brown DL
    Arch Intern Med; 2012 Feb; 172(4):312-9. PubMed ID: 22371919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How should patients with unstable angina and non-ST-segment elevation myocardial infarction be managed? A meta-analysis of randomized trials.
    Choudhry NK; Singh JM; Barolet A; Tomlinson GA; Detsky AS
    Am J Med; 2005 May; 118(5):465-74. PubMed ID: 15866246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-analysis of controlled clinical trials comparing low-molecular weight heparins with unfractionated heparin in unstable angina.
    Malhotra S; Karan RS; Bhargava VK; Pandhi P; Grover A; Sharma YP; Kumar R
    Indian Heart J; 2001; 53(2):197-202. PubMed ID: 11428477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and tolerability of administration of granulocyte colony-stimulating factor on left ventricular function in patients with myocardial infarction: a meta-analysis of randomized controlled trials.
    Kang S; Yang Y; Li CJ; Gao R
    Clin Ther; 2007 Nov; 29(11):2406-18. PubMed ID: 18158081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a meta-analysis of randomised controlled clinical trials.
    Delewi R; Andriessen A; Tijssen JG; Zijlstra F; Piek JJ; Hirsch A
    Heart; 2013 Feb; 99(4):225-32. PubMed ID: 22875736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina.
    Allen KB; Dowling RD; Fudge TL; Schoettle GP; Selinger SL; Gangahar DM; Angell WW; Petracek MR; Shaar CJ; O'Neill WW
    N Engl J Med; 1999 Sep; 341(14):1029-36. PubMed ID: 10502592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipyridamole in chronic stable angina pectoris; a randomized, double blind, placebo-controlled, parallel group study.
    Picano E;
    Eur Heart J; 2001 Oct; 22(19):1785-93. PubMed ID: 11549300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: design of the RENEW study.
    Povsic TJ; Junge C; Nada A; Schatz RA; Harrington RA; Davidson CJ; Fortuin FD; Kereiakes DJ; Mendelsohn FO; Sherman W; Schaer GL; White CJ; Stewart D; Story K; Losordo DW; Henry TD
    Am Heart J; 2013 Jun; 165(6):854-861.e2. PubMed ID: 23708155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy comparison of trimetazidine with therapeutic alternatives in stable angina pectoris: a network meta-analysis.
    Danchin N; Marzilli M; Parkhomenko A; Ribeiro JP
    Cardiology; 2011; 120(2):59-72. PubMed ID: 22122948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy evaluation of clopidogrel compared to ticlopidine after stent implantation: an updated meta-analysis.
    Casella G; Ottani F; Pavesi PC; Sangiorgio P; Rubboli A; Galvani M; Fontanelli A; Bracchetti D
    Ital Heart J; 2003 Oct; 4(10):677-84. PubMed ID: 14664280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmyocardial revascularization: 5-year follow-up of a prospective, randomized multicenter trial.
    Allen KB; Dowling RD; Angell WW; Gangahar DM; Fudge TL; Richenbacher W; Selinger SL; Petracek MR; Murphy D
    Ann Thorac Surg; 2004 Apr; 77(4):1228-34. PubMed ID: 15063241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous transplantation of blood-derived stem/progenitor cells for ischaemic heart disease.
    Wen Y; Meng L; Ding Y; Ouyang J
    Int J Clin Pract; 2011 Aug; 65(8):858-65. PubMed ID: 21762310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trials.
    Henry TD; Losordo DW; Traverse JH; Schatz RA; Jolicoeur EM; Schaer GL; Clare R; Chiswell K; White CJ; Fortuin FD; Kereiakes DJ; Zeiher AM; Sherman W; Hunt AS; Povsic TJ
    Eur Heart J; 2018 Jun; 39(23):2208-2216. PubMed ID: 29315376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis.
    Katritsis DG; Ioannidis JP
    Circulation; 2005 Jun; 111(22):2906-12. PubMed ID: 15927966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Cell Therapy on Cardiovascular Outcomes in Patients With Refractory Angina.
    Jones DA; Weeraman D; Colicchia M; Hussain MA; Veerapen D; Andiapen M; Rathod KS; Baumbach A; Mathur A
    Circ Res; 2019 Jun; 124(12):1786-1795. PubMed ID: 30922167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.